Synthroid (Levothyroxine Sodium) tablets, 150 mcg (0.15 mg), 90 tablets per bottle, Rx Only, NDC 0074-7069-90; ABBOTT LABORATORIES NORTH CHICAGO, IL 60064 U.S.A.
Published January 9, 2013 · Recall initiated: December 4, 2012
Summary
FDA records drug Class II recall D-107-2013, published January 9, 2013 and initiated December 4, 2012. Recalling firm: Abbott Laboratories; Status: Terminated; Reported quantity: 28, 524 bottles; Lot: LOT # 18262A8 Exp. 09/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Error on Declared Strength. Product labeled to contain 150 mcg tablets actually contained 75 mcg tablets.
What to do
Voluntary: Firm initiated · Letter
Get an email if SYNTHROID has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- SYNTHROID
- Manufacturer
- Abbott Laboratories
- Distributor
- US Nationwide and Puerto Rico
- UPC
- 0300747149902
- Lot
- LOT # 18262A8 Exp. 09/13
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASynthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc. NorthNovember 15, 2023
- FDAEpinephrine Injection USP, 1 mL, USP 1:1000 (1 mg/mL), SQ/IM, Hospira, Inc., Lake Forest, IL --- NDCJanuary 9, 2013
- FDAMethylprednisolone Acetate (PF) 80 mg/ml Injection, supplied in 1 mL, 2 mL and 5 mL vials, manufactured by NewJanuary 9, 2013
- FDASynthroid (levothyroxine sodium) Tablets USP, 50 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, NorthOctober 3, 2012
- FDASynthroid (levothyroxine sodium) Tablets USP, 112 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, NorthOctober 3, 2012
- FDASynthroid (levothyroxine sodium) Tablets USP, 75 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, NorthOctober 3, 2012
Questions about this recall
Was Synthroid (Levothyroxine Sodium) tablets, 150 mcg (0.15 mg), 90 tablets per bottle, Rx Only, NDC 0074-7069-90; ABBOTT LABORATORIES NORTH CHICAGO, IL 60064 U.S.A. recalled?
Yes. FDA published recall D-107-2013 on January 9, 2013. Reported hazard: Labeling: Error on Declared Strength. Product labeled to contain 150 mcg tablets actually contained 75 mcg tablets.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: SYNTHROID. UPC: 0300747149902.